You are here: Industry Insights > Japanese

News List

Takeda's Entyvio secures Japanese approval in ulcerative colitis pharmafile
July 06, 2018
As one of the most common forms of inflammatory bowel disease (IBD), ulcerative colitis affects over 220,000 people in Japan.
Biogen acquires licence for Japanese company TMS’ stroke drug pharmatimes
June 13, 2018
Biogen has signed an exclusive option agreement to buy Japan-based biotechnology company TMS’ TMS-007 drug candidate being developed for the treatment of acute ischemic stroke (AIS).
Japanese researchers design device for drug toxicity biospectrumasia
August 29, 2017
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves.
Japanese researchers develop a long-lasting insulin analog biospectrumasia
August 25, 2017
The researchers demonstrated that selenoinsulin analog had a nearly identical structure to that of bovine pancreatic insulin, suggesting that they have similar bioactivity.
Japanese researchers use brain imaging to detect kidney disease biospectrumasia
August 24, 2017
The technique is expected to replace the invasive biopsies currently used to identify patients at risk of developing chronic kidney disease.
Mitsubishi Tanabe Pharma to buy Neuroderm for $1.1 B biospectrumasia
July 27, 2017
The acquisition is intended to help the Japanese drug maker achieve its U.S. sales target of 80 billion yen by FY2020.

Previous page 1 2 Next page